Archive for July 9, 2010
European Agency Reviewing Cardiovascular Safety Of GlaxoSmithKline’s Avandia
Friday, the European Medicines Agency announced that the rosiglitazone-containing anti-diabetes medicines – Avandia, Avandamet and Avaglim, marketed by GlaxoSmithKline plc (GSK) (GSK.L) are being reviewed to determine the safety of the drugs, following new studies questioning their cardiovascular safety.
FDA Warns Of Potentially Harmful Ingredients In Chinese Que She Herbal Weight Loss Pills
If you have been taking the herbal weight loss supplement – Que She (pronounced KAY-Shee), it is better you stop using the product immediately and consult a health care professional, as it contains potentially harmful ingredients, the FDA has warned.
Interserve Says First-Half Trading In Line With Expectations – Update
UK-based building and maintenance company Interserve plc (IRV.L) said Friday, in its trading statement, that trading in the first half was in line with its board’s expectation. Also, the company confirmed that second half weighting of profits would be more pronounced than usual.
FDA Cautions Consumers About Off-Label Use Of Malaria Drug Qualaquin
The off-label use of malaria drug Qualaquin, which contains the active ingredient quinine, to treat night time leg cramps can have serious implications, the U.S. Food and Drug Administration cautioned again on Thursday. A similar warning was made by the regulatory agency in 2006 and the sale of all unapproved drug products containing quinine was [...]